Ten years of Hib vaccination in Italy: Prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance

Vaccine

Volumn 29, Issue 22, 2011, Pages 3857-3862

  Giufrè, Maria ^a   Cardines, Rita ^a   Caporali, Maria Grazia ^a   Accogli, Marisa ^a   D'Ancona, Fortunato ^a   Cerquetti, Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antibiotic resistance; Capsular serotype; Epidemiology; Haemophilus influenzae; Invasive disease

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMIPENEM; PENICILLIN BINDING PROTEIN; ANTIINFECTIVE AGENT; HAEMOPHILUS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INCIDENCE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; VIRUS ISOLATION; VIRUS STRAIN; AGE DISTRIBUTION; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMPICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; ITALY; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 80051758053     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.059     Document Type: Article

References (35)

1. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 1931;53:471.
2. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13:302-17.
3. Wenger JD, Booy R, Heath PT, Moxon ER. Epidemiological impact of conjugate vaccines on invasive disease caused by Haemophilus influenzae type b. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines. 2nd ed. New York: Marcel Decker; 1997. p. 489-502.
4. Adderson EE, Byington CL, Spencer L, et al. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics 2001;108:E18.
5. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, Petersen M, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003;187(1):109-16.
6. Ladhani S, Ramsay ME, Chandra M, Slack MP. EU-IBIS, No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis 2008;8(5):275-6.
7. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010;28(24):4073-8.
8. Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, et al. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis 2010;50(7):e41-6.
9. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ≥65 years old. Clin Infect Dis 2007;44(6):810-6.
10. Sarangi J, Cartwright K, Stuart J, Brookes S, Morris R, Slack M. Invasive Haemophilus influenzae disease in adults. Epidemiol Infect 2000;124(3):441-7.
11. Cerquetti M, Ciofi degli Atti ML, Cardines RS Salmaso S, Renna G, Mastrantonio P, et al. Invasive type e Haemophilus influenzae disease in Italy. Emerg Infect Dis 2003;9(2):258-61.
12. Ciofidegli Atti ML, Cerquetti M, Tozzi AE, Mastrantonio P, Salmaso S, Haemophilus influenzae Study Group. Haemophilus influenzae invasive disease in Italy, 1997-1998. Eur J Clin Microbiol Infect Dis 2001;20(6):436-7.
13. Falla TJ, Crook DWM, Brophy LN, Maskell D, Kroll JS, Moxon ER. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994;32:2382-6.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: fifteenth informational supplement, M7-S15, vol. 28(1). Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
15. Cerquetti M, Cardines R, Giufrè M, Mastrantonio P, Hi study group. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from invasive disease in Italy. J Antimicrob Chemother 2004;54:1139-43.
16. Cardines R, Giufrè M, Mastrantonio P, Ciofi degli Atti ML, Cerquetti M. Nontypeable Haemophilus influenzae meningitis in children: phenotypic and genotypic characterization of isolates. Pediatr Infect Dis J 2007;26(7):577-82.
17. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000;31:973-80.
18. Heath PT, Booy R, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, et al. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J 2001;20:300-5.
19. Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME. European Union Invasive Bacterial Infection Surveillance participants. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg Infect Dis 2010;16(3):455-63.
20. Campos J, Hernando M, Román F, Pérez-Vázquez M, Aracil B, Oteo J, et al. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol 2004;42:524-9.
21. Brown VM, Madden S, Kelly L, Jamieson FB, Tsang RS, Ulanova M. Invasive Haemophilus influenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002-2008. Clin Infect Dis 2009;49(8):1240-3.
22. Bruce MG, Deeks SL, Zulz T, Navarro C, Palacios C, Case C, et al. Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Emerg Infect Dis 2008;14(1):48-55.
23. Millar EV, O'Brien KL, Watt JP, Lingappa J, Pallipamu R, Rosenstein N, et al. Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Clin Infect Dis 2005;40(6):823-30.
24. Tsang RS, Sill ML, Skinner SJ, Law DK, Zhou J, Wylie J. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis 2007;44(12):1611-4.
25. Cerquetti M, Ciofi degli Atti ML, Renna G, Tozzi AE, Garlaschi ML, Mastrantonio P, et al. Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. J Clin Microbiol 2000;38(12):4649-52.
26. Cerquetti M, Ciofi degli Atti ML, Cardines R, Giufre M, Romano A, Mastrantonio P. Haemophilus influenzae serotype e meningitis in an infant. Clin Infect Dis 2004;38(7):1041.
27. Tsang R. Capsule switching and capsule replacement in vaccine-preventable bacterial diseases. Lancet Infect Dis 2007;7(9):569-70.
28. García-Cobos S, Campos J, Cercenado E, Román F, Lázaro E, Pérez-Vázquez M, et al. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob Agents Chemother 2008;52(8):2760-6.
29. Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, et al. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother 2005;49:2561-4.
30. Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother 2006;58:873-7.
31. Ladhani S, Heath PT, Ramsay ME, Slack MP. Changes in antibiotic resistance rates of invasive Haemophilus influenzae isolates in England and Wales over the last 20 years. J Antimicrob Chemother 2008;62(4):776-9.
32. Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob Agents Chemother 2010;54(7):2953-9.
33. Markowitz SM. Isolation of an ampicillin-resistant, non-beta-lactamase producing strain of Haemophilus influenzae. Antimicrob Agents Chemother 1980;17:80-3.
34. Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, et al. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002;46:2208-18.
35. Cerquetti M, Giufrè M, Cardines R, Mastrantonio P. First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Antimicrob Agents Chemother 2007;51(9):3155-61.